| abstract |
Use of mycosporine-like amino acid (shinorine)nin products for prevention and treatment of actinic erythema,nphotocarcinogenesis and photoaging.n n n The present invention is part of the biotechnology sector and refers to the use of a mycosporin-like amino acid (MAA), specifically shinorine isolated from Gymnogongrus devoniensis red algae, in the preparation of parapharmacy products, pharmaceutical products, nutraceutical preparations, or in food functional, for the prevention and therapeutic treatment of actinic erythema, photocarcinogenesis and photoaging. |